Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Nuvation Bio Inc.
Exelixis
Tango Therapeutics, Inc.
Haihe Biopharma Co., Ltd.
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
AstraZeneca